Sianturi, E., Perwitasari, D. A., Soltief, S. N., Islam, M. A., Geboers, B., & Taxis, K. (2021). Health literacy of people living with HIV in a rural area in Indonesia: A cross-sectional study. Health & Social Care in the Community, 29(1), 127-134. https://doi.org/10.1111/hsc.13075

van der Schans, J., Hak, E., Postma, M., Breuning, L., Brouwers, J. R. B. J., Ditters, K., Jansen, P. A. F., Kok, R. M., Maring, J. G., van Marum, R., Mulder, H., Nanninga, J., Voshaar, R. C. O., Risselada, A. J., Vleugel, L., Stek, M., van Schaik, R. H. N., Berm, E. J. J., & Wilffert, B. (2020). Article Selected to Receive the Mitchell B. Balter Award for 2020. Journal of Clinical Psychopharmacology, 40(5), 443-443. https://doi.org/10.1097/JCP.0000000000001273

Arends, S., Wink, F., Veneberg, J., Bos, R., van Roon, E., van der Veer, E., Maas, F., & Spoorenberg, A. (2020). Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.14431

van Eersel, M. E. A., Visser, S. T., Joosten, H., Gansevoort, R. T., Slaets, J. P. J., & Izaks, G. J. (2020). Pharmacological treatment of increased vascular risk and cognitive performance in middle-aged and old persons: six-year observational longitudinal study. BMC NEUROLOGY, 20(1), [242]. https://doi.org/10.1186/s12883-020-01822-0

Chaves, T. V., Wilffert, B., & Sanchez, Z. M. (2020). The use of ketamine to cope with depression and post-traumatic stress disorder: A qualitative analysis of the discourses posted on a popular online forum. American journal of drug and alcohol abuse, 1-12. https://doi.org/10.1080/00952990.2020.1769118

Fedorenko, O. Y., Paderina, D. Z., Loonen, A. J. M., Pozhidaev, I., Boiko, A. S., Kornetova, E. G., Bokhan, N. A., Wilffert, B., & Ivanova, S. A. (2020). Association of ANKK1 polymorphism with antipsychotic-induced hyperprolactinemia. Human Psychopharmacology, 35(4), [2737]. https://doi.org/10.1002/hup.2737

Bahar, M. A., Bos, J. H. J., Borgsteede, S. D., Dotinga, A., Alingh, R. A., Wilffert, B., & Hak, E. (2020). Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross-Sectional Descriptive Study as Part of the PharmLines Initiative. Frontiers in Pharmacology, 11, [624]. https://doi.org/10.3389/fphar.2020.00624

Glerum, P. J., Maliepaard, M., de Valk, V., Scholl, J. H. G., van Hunsel, F. P. A. M., van Puijenbroek, E. P., Burger, D. M., & Neef, K. (2020). Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands. Clinical and translational science, 13(3), 599-607. https://doi.org/10.1111/cts.12746

Pozhidaev, I., Paderina, D. Z., Fedorenko, O. Y., Kornetova, E. G., Semke, A., Loonen, A. J. M., Bokhan, N. A., Wilffert, B., & Ivanova, S. A. (2020). 5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia. Frontiers in Molecular Neuroscience, 13, [63]. https://doi.org/10.3389/fnmol.2020.00063

Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Schmidt, A. F., Cohen, D., Boiko, A. S., Paderina, D. Z., Fedorenko, O. Y., Semke, A. V., Bokhan, N. A., Wilffert, B., Kosterink, J. G. W., Touw, D. J., & Loonen, A. J. M. (2020). Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia. British Journal of Clinical Pharmacology, 86(9), 1827-1835. https://doi.org/10.1111/bcp.14288

Schreuder, N., de Hoog, Q., de Vries, S. T., Jager, P. L., Kosterink, J. G. W., & van Puijenbroek, E. P. (2020). Patient-Reported Adverse Events of Radiopharmaceuticals: Development and Validation of a Questionnaire. Drug Safety, 43(4), 319-328. https://doi.org/10.1007/s40264-019-00895-2

Rolfes, L., Haaksman, M., van Hunsel, F., & van Puijenbroek, E. (2020). Insight into the Severity of Adverse Drug Reactions as Experienced by Patients. Drug Safety, 43(3), 291–293. https://doi.org/10.1007/s40264-019-00890-7

Jorritsma-Smit, A., van Zanten, C. J., Schoemaker, J., Meulenberg, J. J. M., Touw, D. J., Kosterink, J. G. W., Nijman, H. W., Daemen, T., & Allersma, D. P. (2020). GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles. European Journal of Pharmaceutical Sciences, 143, [105096]. https://doi.org/10.1016/j.ejps.2019.105096

Losenkov, I. S., Mulder, N. J. V., Levchuk, L. A., Vyalova, N. M., Loonen, A. J. M., Bosker, F. J., Simutkin, G. G., Boiko, A. S., Bokhan, N. A., Wilffert, B., Hak, E., Schmidt, A. F., & Ivanova, S. A. (2020). Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients. Frontiers in Psychiatry, 11, [38]. https://doi.org/10.3389/fpsyt.2020.00038

Irawati, S., Dharma, S., Taxis, K., Nguyen, T., Nursyarofah, N., Wilffert, B., & Hak, E. (2020). Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to a Tertiary Care Academic Center in a Developing Country. Global heart, 15(1), 8. https://doi.org/10.5334/gh.394

Ochi, T., Vyalova, N. M., Losenkov, I. S., Levchuk, L. A., Osmanova, D. Z., Mikhalitskaya, E. V., Loonen, A. J. M., Bosker, F. J., Simutkin, G. G., Bokhan, N. A., Wilffert, B., & Ivanova, S. A. (2019). Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients. Journal of Affective Disorders, 259, 432-439. https://doi.org/10.1016/j.jad.2019.08.058

Ivanova, S. A., Boiko, A. S., Mednova, I. A., Kornetova, E. G., & Loonen, A. J. M. (2019). P.374 Cortisol and DHEAS related to metabolic side effects in patients with schizophrenia. European Neuropsychopharmacology, 29(Supp. 6), S265-S266. https://doi.org/10.1016/j.euroneuro.2019.09.389

Boiko, A. S., Kornetova, E. G., Mednova, I. A., Loonen, A. J. M., & Ivanova, S. A. (2019). P.390 Characteristics of metabolic hormones in patients with schizophrenia with antipsychotic-induced metabolic syndrome. European Neuropsychopharmacology, 29, S276-S277. https://doi.org/10.1016/j.euroneuro.2019.09.404

Vyalova, N., Ochi, T., Losenkov, I., Levchuk, L., Osmanova, D., Mikhalitskaya, E., Loonen, A. J. M., Bosker, F. J., Simutkin, G., Bokhan, N., Wilffert, B., & Ivanova, S. (2019). P.505 The potential role of BDNF and prolactin genotypes on antidepressant response in depressive patients. European Neuropsychopharmacology, 29(Suppl. 6), S355-S356. https://doi.org/10.1016/j.euroneuro.2019.09.511

Nguyen, T., Cao, H. T. K., Quach, D. N., Le, K. K., Au, S. X., Pham, S. T., Nguyen, T. H., Pham, T. T., & Taxis, K. (2019). The Vietnamese Version of the Brief Illness Perception Questionnaire and the Beliefs about Medicines Questionnaire: Translation and Cross-cultural Adaptation. Tropical Medicine & International Health, 24(12), 1465-1474. https://doi.org/10.1111/tmi.13312

van der Schans, J., Hak, E., Postma, M., Breuning, L., Brouwers, J. R. B. J., Ditters, K., Jansen, P. A. F., Kok, R. M., Maring, J. G., van Marum, R., Mulder, H., Nanninga, J., Oude Voshaar, R. C., Risselada, A. J., Vleugel, L., Stek, M., van Schaik, R. H. N., Berm, E. J. J., & Wilffert, B. (2019). Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial). Journal of Clinical Psychopharmacology, 39(6), 583-590. https://doi.org/10.1097/JCP.0000000000001129

Martono, D. P., Heerspink, H. J. L., Hak, E., Denig, P., & Wilffert, B. (2019). No significant association of type 2 diabetes-related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives. Diabetes obesity & metabolism, 21(10), 2267-2273. https://doi.org/10.1111/dom.13803

Wouters, H., Foster, J. M., Ensink, A., O'Donnell, L. K., Zuidema, S. U., Boersma, F., & Taxis, K. (2019). Barriers and Facilitators of Conducting Medication Reviews in Nursing Home Residents: A Qualitative Study. Frontiers in Pharmacology, 10, [1026]. https://doi.org/10.3389/fphar.2019.01026

Boom, F. A., Le Brun, P. P. H., Boehringer, S., Kosterink, J. G. W., & Touw, D. (2019). Improving the aseptic transfer procedures in hospital pharmacies. Part B: evaluation of disinfection methods for materials with a non-sterile surface. European Journal of Hospital Pharmacy: Science and Practice, ejhpharm-2018-001673. https://doi.org/10.1136/ejhpharm-2018-001673

Boiko, A. S., Mednova, I. A., Kornetova, E. G., Semke, A. V., Bokhan, N. A., Loonen, A. J. M., & Ivanova, S. A. (2019). Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia. Heliyon, 5(7), [e02033]. https://doi.org/10.1016/j.heliyon.2019.e02033

Loonen, A. J. M., & Ivanova, S. A. (2019). Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD. Pharmacopsychiatry, 52(4), 203-204. https://doi.org/10.1055/a-0835-6447

Larmené-Beld, K. H. M., Frijlink, H. W., & Taxis, K. (2019). A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment. European Journal of Clinical Pharmacology, 75(5), 609-617. https://doi.org/10.1007/s00228-019-02631-2

Holvast, F., Oude Voshaar, R. C., Wouters, H., Hek, K., Schellevis, F., Burger, H., & Verhaak, P. F. M. (2019). Non-adherence to antidepressants among older patients with depression: a longitudinal cohort study in primary care. Family practice, 36(1), 12-20. https://doi.org/10.1093/fampra/cmy106

Holvast, F., Wouters, H., Hek, K., Schellevis, F., Voshaar, R. O., van Dijk, L., Burger, H., & Verhaak, P. (2019). Non-adherence to cardiovascular drugs in older patients with depression: A population-based cohort study. International Journal of Cardiology, 274, 366-371. https://doi.org/10.1016/j.ijcard.2018.08.100

Rolfes, L., Ekhart, C., Hendriks, J., van der Horst, P., & van Puijenbroek, E. (2019). Safety profile of non-vitamin K oral anticoagulants (NOACs) from a patient perspective: A web-based cohort event monitoring study. Expert Opinion on Drug Safety, 18(9), 869-874. https://doi.org/10.1080/14740338.2019.1645120

Wang, Y., Zijp, T. R., Bahar, M. A., Kocks, J. W. H., Wilffert, B., & Hak, E. (2018). Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy, 73(12), 3231–3243. https://doi.org/10.1093/jac/dky326

Schuiling-Veninga, C., & Pras, N. (2018). Student ontwikkelt zich tot zelfbewuste professional. Pharmaceutisch Weekblad, 47. https://www.pw.nl/achtergrond/2018/student-ontwikkelt-zich-tot-zelfbewuste-professional

van Berlo-van de Laar, I. R. F., Brummelhuis, W. J., Imholz, A. L. T., Schellens, J. H., Huitema, A. D. R., & Jansman, F. G. A. (2018). Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations. Journal of Clinical Pharmacy and Therapeutics, 43(4), 574-577. https://doi.org/10.1111/jcpt.12661

Rolfes, L., van Hunsel, F., Caster, O., Taavola, H., Taxis, K., & van Puijenbroek, E. (2018). Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database: A Retrospective Comparison of Time to Reporting Between Patients and Healthcare Professionals in a Global Database. British Journal of Clinical Pharmacology, 84(7), 1514-1524. https://doi.org/10.1111/bcp.13576

Dijkstra, J. A., van der Laan, T., Akkerman, O. W., Bolhuis, M. S., de lange, W. C. M., Kosterink, J. G. W., van der Werf, T. S., Alffenaar, J. W. C., & van Soolingen, D. (2018). In Vitro Susceptibility of Mycobacterium tuberculosis to Amikacin, Kanamycin, and Capreomycin. Antimicrobial Agents and Chemotherapy, 62(3), [e01724-17]. https://doi.org/10.1128/AAC.01724-17

Schutte, T., van Eekeren, R., Richir, M., van Staveren, J., van Puijenbroek, E., Tichelaar, J., & van Agtmael, M. (2018). The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study. Naunyn-Schmiedebergs Archives of Pharmacology, 391(1), 17-26. https://doi.org/10.1007/s00210-017-1430-z

Riphagen, I. J., Keyzer, C. A., Drummen, N. E. A., de Borst, M. H., Beulens, J. W. J., Gansevoort, R. T., Geleijnse, J. M., Muskiet, F. A. J., Navis, G., Visser, S. T., Vermeer, C., Kema, I. P., & Bakker, S. J. L. (2017). Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study. Nutrients, 9(12), [1334]. https://doi.org/10.3390/nu9121334

Stuijt, C. C. M., Van der Bemt, B., Boerlage, V. E., Taxis, K., & Karapinar, F. (2017). Determinants for medication reconciliation interventions on hospital admission and discharge: An observational multi-centre study. European Journal of Internal Medicine, 46, e20-e22. https://doi.org/10.1016/j.ejim.2017.09.001

Sanders, L. M. J., Hortobágyi, T., van Staveren, G., Taxis, K., Boersma, F., Klein, H. C., Bossers, W. J. R., Blankevoort, C. G., Scherder, E. J. A., van der Zee, E. A., & van Heuvelen, M. J. G. (2017). Relationship between drug burden and physical and cognitive functions in a sample of nursing home patients with dementia. European Journal of Clinical Pharmacology, 73(12), 1633-1642. https://doi.org/10.1007/s00228-017-2319-y

Krabbe, P. F. M., Stolk, E. A., Devlin, N. J., Xie, F., Quik, E. H., & Pickard, A. S. (2017). Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale. European Journal of Health Economics, 18(8), 967-977. https://doi.org/10.1007/s10198-016-0841-y

Simoons, M., Mulder, H., Schoevers, R. A., Ruhe, H. G., & Van Roon, E. N. (2017). Overdracht van CYP2D6-genotyperingsuitslagen naar huisarts en openbare apotheek. Pharmaceutisch Weekblad, 152(43), 27-31.

Geers, L. M., Pozhidaev, I. V., Ivanova, S. A., Freidin, M. B., Cohen, D., Boiko, A. S., Osmanova, D. Z., Fedorenko, O. Y., Touw, D. J., Semke, A. V., Wilffert, B., Bokhan, N. A., & Loonen, A. J. M. (2017). Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia. European Neuropsychopharmacology, 27(Supplement 4), S956. https://doi.org/10.1016/S0924-977X(17)31689-9

Rolfes, L., Haaksman, M., van Hunsel, F., & van Puijenbroek, E. (2017). How do Adverse Drug Reactions Influence the Patient's Daily Life? Qualitative Analysis on Spontaneous Reports by Patients. Drug Safety, 40(10), 964-964.

Nuntamool, N., Ngamsamut, N., Vanwong, N., Puangpetch, A., Chamnanphon, M., Hongkaew, Y., Limsila, P., Suthisisang, C., Wilffert, B., & Sukasem, C. (2017). Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents. Basic & clinical pharmacology & toxicology, 121(4), 316-324. https://doi.org/10.1111/bcpt.12803

Wouters, H., Scheper, J., Koning, H., Brouwer, C., Twisk, J., Van Der Meer, H., Boersma, F., Zuidema, S., & Taxis, K. (2017). Discontinuing Inappropriate Medication in Nursing Home Residents (DIM-NHR study): A cluster randomized controlled trial. European geriatric medicine, 8(S1-S39), 16. https://doi.org/10.1016/S1878-7649(17)30178-X

Kovačević, S. V., Miljković, B., Vučićević, K., Ćulafić, M., Kovačević, M., Golubović, B., Jovanović, M., & de Gier, J. J. (2017). Elderly polypharmacy patients' needs and concerns regarding medication assessed using the structured patient-pharmacist consultation model. Patient Education and Counseling, 100(9), 1714-1719. https://doi.org/10.1016/j.pec.2017.05.001

Berhe, D. F., Taxis, K., Haaijer-Ruskamp, F. M., Mulugeta, A., Mengistu, Y. T., Burgerhof, J. G. M., & Mol, P. G. M. (2017). Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patients. British Journal of Clinical Pharmacology, 83(9), 2107-2117. https://doi.org/10.1111/bcp.13312

Warnders, F-J., Terwisscha van Scheltinga, A. G., Knuehl, C., van Roy, M., de Vries, E. F., Kosterink, J. G. W., de Vries, E. G. E., & Lub-de Hooge, M. N. (2017). Human Epidermal Growth Factor Receptor 3-Specific Tumor Uptake and Biodistribution of Zr-89-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging. Journal of Nuclear Medicine, 58(8), 1210-1215. https://doi.org/10.2967/jnumed.116.181586

Kovačević, S. V., Miljković, B., Ćulafić, M., Kovačević, M., Golubović, B., Jovanović, M., Vučićević, K., & de Gier, J. J. (2017). Evaluation of drug-related problems in older polypharmacy primary care patients. Journal of Evaluation in Clinical Practice, 23(4), 860-865. https://doi.org/10.1111/jep.12737

Aardema, H., Nannan Panday, P., Wessels, M., van Hateren, K., Dieperink, W., Kosterink, J. G. W., Alffenaar, J-W., & Zijlstra, J. G. (2017). Target attainment with continuous dosing of piperacillin/tazobactam in critical illness: A prospective observational study. International journal of antimicrobial agents, 50(1), 68-73. https://doi.org/10.1016/j.ijantimicag.2017.02.020